ITGR Integer Holdings Corporation

Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025

Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025

~ Attendees Invited to Visit Integer at Booth #1439 ~

PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California.

Integer welcomes visitors to booth #1439 to learn more about the company’s commitment to customers as their partner of choice in enhancing the lives of patients through access to innovative technologies, superior quality and dependable manufacturing to accelerate speed to market and reduce product development risk.

Integer’s exhibit will showcase capabilities and solutions to enable cardio and vascular, cardiac rhythm management and neuromodulation products, and how the company blends technology, expertise and resources to amplify customers’ innovation.  

Integer will additionally highlight its global rapid prototyping services that enable customers’ direct access to a team of dedicated experts in R&D and engineering. With a local-to-local approach and as little as a two-week turnaround, customers now can obtain rapid prototypes in specialized cardiovascular markets, including structural heart, electrophysiology and neurovascular. Offerings include catheter shafts and guidewires, steerable sheaths, introducers, braiding and textiles, and machined components.

“As we expand our capabilities and capacity through ongoing strategic investments, we will continue to anticipate our customers’ needs in a highly innovative and rapidly evolving medical device landscape,” said Payman Khales, President, Cardio and Vascular. “We look forward to demonstrating our collaborative approach, continued commitment to innovation, and the strategic value we provide as our customers’ trusted and reliable end-to-end partner in medical device technologies.”

Integer will also showcase a range of key product areas throughout the event, including:

  • Cardiac rhythm management and neuromodulation: Miniaturized technology for finished IPGs as well as Gen 3 Li Ion and Gen 2 CFx batteries.
  • Cardio and vascular solutions: A full range of electrophysiology, structural heart, and neurovascular product solutions including complex catheters, high-performing guidewires, steerable introducers and sheaths, therapy delivery systems, and implant technologies.

In addition to Integer’s exhibit at booth #1439, MD&M West 2025 attendees can visit Pulse Technologies, an Integer Company, at booth #2854 to learn more about HSR technology and complex micro machining for critical medical device components.

Attendees are also invited to visit Precision Coating at booth #2269. Integer acquired substantially all of the assets of Precision Coating, a privately held manufacturer specializing in high value surface coating technology platforms, including fluoropolymer, anodic coatings, ion treatment solutions and laser processing, on Jan. 7, 2025, for $152 million, subject to adjustment for additional contingent consideration. Consistent with Integer’s tuck-in acquisition strategy, the acquisition of Precision Coating increases Integer’s service offerings to include differentiated and proprietary coatings capabilities that position Integer to better meet customers’ evolving needs.

Integer will share additional details on this acquisition during its fourth quarter and full year 2024 earnings call on Feb. 20, 2025.

Learn more about Integer at .

About Integer®

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at .

Investor Relations:Media Relations:
Andrew Senn Kelly Butler
763.951.8312469.731.6617


EN
03/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integer Holdings Corporation

 PRESS RELEASE

Integer Holdings Corporation Reports Results for Fourth Quarter and Fu...

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025 ~ Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth and high end of adjusted EPS growth from October outlook ~~ Continue to expect 200bps above-market organic sales growth in 2027 ~ PLANO, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2025. Unless otherwise stat...

 PRESS RELEASE

Integer to Highlight Integrated R&D Solutions and Expanded Coating Cap...

Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities During MD&M West 2026 Attendees Invited to Experience Integer’s New Booth #3201 PLANO, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will exhibit during MD&M West 2026 in Anaheim, Calif., Feb. 3 – 5. Integer will unveil a significantly expanded 20 x 50 sq. ft. new booth #3201, showcasing the company’s full range of customer solutions. On prominent display will b...

 PRESS RELEASE

Integer Announces Conference Call to Discuss Fourth Quarter and Full Y...

Integer Announces Conference Call to Discuss Fourth Quarter and Full Year 2025 Results PLANO, Texas, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the fourth quarter and year ended Dec. 31, 2025, on Thursday, Feb. 19, 2026, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information may also be discussed during this call. The company will issue a news release announcing financial results for the fourth quarter and full year on Feb. 19...

 PRESS RELEASE

Integer to Showcase Innovations in Neuromodulation, Miniaturized Activ...

Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting ~ Attendees Invited to Visit Integer at Booth #115 ~ PLANO, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) --  Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will join global medtech leaders and innovators in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas from Jan. 22 – 25, 2026. At booth #115, Integer will spotlight...

 PRESS RELEASE

Integer to Participate at Upcoming Investor Conferences

Integer to Participate at Upcoming Investor Conferences PLANO, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, announced today that members of its executive leadership team will participate at the following investor conferences in December: Piper Sandler 37th Annual Healthcare Conference at 8:00 a.m. ET on Tuesday, Dec. 2Citi’s 2025 Global Healthcare Conference at 9:45 a.m. ET on Wednesday, Dec. 3 A live webcast and replay for each event will be accessible under “News & Even...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch